190 related articles for article (PubMed ID: 17270658)
1. Evaluation of AIbZIP and Cdc47 as markers for human prostatic diseases.
Levesque MH; El-Alfy M; Berger L; Labrie F; Labrie C
Urology; 2007 Jan; 69(1):196-201. PubMed ID: 17270658
[TBL] [Abstract][Full Text] [Related]
2. DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer.
Padmanabhan V; Callas P; Philips G; Trainer TD; Beatty BG
J Clin Pathol; 2004 Oct; 57(10):1057-62. PubMed ID: 15452160
[TBL] [Abstract][Full Text] [Related]
3. Activator protein 2alpha transcription factor expression is associated with luminal differentiation and is lost in prostate cancer.
Ruiz M; Troncoso P; Bruns C; Bar-Eli M
Clin Cancer Res; 2001 Dec; 7(12):4086-95. PubMed ID: 11751506
[TBL] [Abstract][Full Text] [Related]
4. Expression of hypoxia-inducible factor 1alpha in human normal, benign, and malignant prostate tissue.
Du Z; Fujiyama C; Chen Y; Masaki Z
Chin Med J (Engl); 2003 Dec; 116(12):1936-9. PubMed ID: 14687488
[TBL] [Abstract][Full Text] [Related]
5. Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia.
Maygarden SJ; Strom S; Ware JL
Arch Pathol Lab Med; 1992 Mar; 116(3):269-73. PubMed ID: 1371380
[TBL] [Abstract][Full Text] [Related]
6. The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.
Monsef N; Soller M; Isaksson M; Abrahamsson PA; Panagopoulos I
Prostate; 2009 Jun; 69(9):909-16. PubMed ID: 19274762
[TBL] [Abstract][Full Text] [Related]
7. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer.
Hermani A; Hess J; De Servi B; Medunjanin S; Grobholz R; Trojan L; Angel P; Mayer D
Clin Cancer Res; 2005 Jul; 11(14):5146-52. PubMed ID: 16033829
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor as a potential sign of prostate cancer metastasis.
Lévesque MH; El-Alfy M; Cusan L; Labrie F
Prostate; 2009 Nov; 69(15):1704-11. PubMed ID: 19670238
[TBL] [Abstract][Full Text] [Related]
9. Over expression of ID-1 in prostate cancer.
Ouyang XS; Wang X; Lee DT; Tsao SW; Wong YC
J Urol; 2002 Jun; 167(6):2598-602. PubMed ID: 11992094
[TBL] [Abstract][Full Text] [Related]
10. Androgen-regulated transcription factor AIbZIP in prostate cancer.
Labrie C; Lessard J; Ben Aicha S; Savard MP; Pelletier M; Fournier A; Lavergne E; Calvo E
J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):237-44. PubMed ID: 17933519
[TBL] [Abstract][Full Text] [Related]
11. pS2 (TFF1) expression in prostate carcinoma: correlation with steroid receptor status.
Abdou AG; Aiad HA; Sultan SM
APMIS; 2008 Nov; 116(11):961-71. PubMed ID: 19132993
[TBL] [Abstract][Full Text] [Related]
12. [Androgen and estrogen receptors in intact, hyperplastic, peritumorous and malignant prostate tissues: a link to proliferation and apoptosis (immunochemical study)].
Fedosenko KV; Koval'skiĭ GB
Vopr Onkol; 2005; 51(2):216-8. PubMed ID: 16223004
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional profiling of genes that are regulated by the endoplasmic reticulum-bound transcription factor AIbZIP/CREB3L4 in prostate cells.
Ben Aicha S; Lessard J; Pelletier M; Fournier A; Calvo E; Labrie C
Physiol Genomics; 2007 Oct; 31(2):295-305. PubMed ID: 17712038
[TBL] [Abstract][Full Text] [Related]
14. Preliminary studies on the isolation and characterization of predominant prostatic proteins.
Lombardo ME; Meyer-Siegler K; Hakky SI; Hudson PB
Prostate; 1996 Dec; 29(6):381-5. PubMed ID: 8977635
[TBL] [Abstract][Full Text] [Related]
15. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma.
Hussein MR; Al-Assiri M; Musalam AO
Exp Mol Pathol; 2009 Apr; 86(2):108-13. PubMed ID: 19111537
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies.
Stewart J; Fleshner N; Cole H; Toi A; Sweet J
J Urol; 2008 May; 179(5):1751-5; discussion 1755. PubMed ID: 18343427
[TBL] [Abstract][Full Text] [Related]
18. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells.
Paju A; Hotakainen K; Cao Y; Laurila T; Gadaleanu V; Hemminki A; Stenman UH; Bjartell A
Eur Urol; 2007 Dec; 52(6):1670-9. PubMed ID: 17306443
[TBL] [Abstract][Full Text] [Related]
20. Co-assessment of cytoplasmic and nuclear androgen receptor location in prostate specimens: potential implications for prostate cancer development and prognosis.
Diallo JS; Aldejmah A; Mouhim AF; Fahmy MA; Koumakpayi IH; Sircar K; Bégin LR; Mes-Masson AM; Saad F
BJU Int; 2008 May; 101(10):1302-9. PubMed ID: 18294307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
